Trial Title:
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
NCT ID:
NCT05673148
Condition:
Metastatic Colorectal Adenocarcinoma
Stage IV Colorectal Cancer AJCC v8
Conditions: Official terms:
Colorectal Neoplasms
Study type:
Interventional
Study phase:
Phase 3
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
Stereotactic Ablative Radiotherapy
Description:
Undergo SABR
Arm group label:
Arm 1 (TAT, SOC chemotherapy
Other name:
SABER
Other name:
SABR/SBRT
Intervention type:
Procedure
Intervention name:
Resection
Description:
undergo surgical resection
Arm group label:
Arm 1 (TAT, SOC chemotherapy
Other name:
Surgical resection
Intervention type:
Procedure
Intervention name:
Microwave Ablation
Description:
undergo microwave ablation
Arm group label:
Arm 1 (TAT, SOC chemotherapy
Other name:
Ablation
Intervention type:
Drug
Intervention name:
Chemotherapy
Description:
Receive SOC chemotherapy
Arm group label:
Arm 1 (TAT, SOC chemotherapy
Arm group label:
Arm 2 (SOC chemotherapy)
Other name:
Chemo
Intervention type:
Procedure
Intervention name:
Computed Tomography
Description:
Undergo CT scan
Arm group label:
Arm 1 (TAT, SOC chemotherapy
Arm group label:
Arm 2 (SOC chemotherapy)
Other name:
CAT
Other name:
CAT Scan
Other name:
Computed Axial Tomography
Other name:
CT Scan
Intervention type:
Procedure
Intervention name:
Magnetic Resonance Imaging
Description:
Undergo MRI
Arm group label:
Arm 1 (TAT, SOC chemotherapy
Arm group label:
Arm 2 (SOC chemotherapy)
Other name:
MRI
Intervention type:
Procedure
Intervention name:
Positron Emission Tomography
Description:
Undergo PET scan
Arm group label:
Arm 1 (TAT, SOC chemotherapy
Arm group label:
Arm 2 (SOC chemotherapy)
Other name:
Medical Imaging, Positron Emission Tomography
Other name:
PET
Other name:
PET Scan
Summary:
This phase III trial compares total ablative therapy and usual systemic therapy to usual
systemic therapy alone in treating patients with colorectal cancer that has spread to up
to 4 body sites (limited metastatic). The usual approach for patients who are not
participating in a study is treatment with intravenous (IV) (through a vein) and/or oral
medications (systemic therapy) to help stop the cancer sites from getting larger and the
spread of the cancer to additional body sites. Ablative means that the intention of the
local treatment is to eliminate the cancer at that metastatic site. The ablative local
therapy will consist of very focused, intensive radiotherapy called stereotactic ablative
radiotherapy (SABR) with or without surgical resection and/or microwave ablation, which
is a procedure where a needle is temporarily inserted in the tumor and heat is used to
destroy the cancer cells. SABR, surgical resection, and microwave ablation have been
tested for safety, but it is not scientifically proven that the addition of these
treatments are beneficial for your stage of cancer. The addition of ablative local
therapy to all known metastatic sites to the usual approach of systemic therapy could
shrink or remove the tumor(s) or prevent the tumor(s) from returning.
Detailed description:
PRIMARY OBJECTIVE:
I. To evaluate and compare overall survival (OS) (measured from time of randomization) in
patients with newly diagnosed oligometastatic colorectal cancer (oCRC) treated with total
ablative therapy (TAT) in addition to standard of care (SOC) systemic therapy versus SOC
systemic therapy.
SECONDARY OBJECTIVES:
I. To evaluate and compare event-free survival (EFS) (measured from time of
randomization) between the two treatment arms.
II. To assess the adverse events (AE) profile within each of the two treatment arms.
III. To evaluate the time to local recurrence (TLR) (measured from completion of TAT) in
patients with newly diagnosed oCRC treated with TAT + SOC systemic therapy.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM 1: Patients undergo TAT on study, consisting of SABR with or without surgical
resection and/or microwave ablation. Patients also receive SOC chemotherapy on study.
Patients also undergo computed tomography (CT) or magnetic resonance imaging (MRI) or
positron emission tomography (PET)/CT scans throughout the trial.
ARM 2: Patients receive SOC chemotherapy on study. Patients also undergo Patients also
undergo CT or MRI or PET/CT scans throughout the trial.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- PRE-REGISTRATION (STEP 0): Histologically-confirmed metastatic colorectal
adenocarcinoma
- PRE-REGISTRATION (STEP 0): No known microsatellite instable (MSI) tumor
- PRE-REGISTRATION (STEP 0): No known BRAF V600E mutation
- PRE-REGISTRATION (STEP 0): Patients with treated brain metastases are eligible if
follow-up brain imaging after central nervous system (CNS)-directed therapy shows no
evidence of progression. No known peritoneal and/or omental metastases. If
radiologic studies suggest the presence of peritoneal disease, a diagnostic
laparoscopy is recommended to verify the absence of peritoneal implants
- PRE-REGISTRATION (STEP 0): Primary tumor is already resected OR primary tumor is
surgically amenable to resection, as determined by consultation and documentation
with surgeon or documentation of discussion in the institutional multi-disciplinary
tumor board where a surgeon confirms resectability. Patients with unresectable
primary tumors are not eligible
- PRE-REGISTRATION (STEP 0): Four (4) or fewer apparent sites of metastatic disease
based on review by local medical team of baseline radiographic imaging obtained
prior to initiation of systemic therapy.
- Sites of metastatic disease must be radiographically evident, but pathologic
confirmation is not required.
- Liver-only metastatic disease is NOT permitted. For patients with liver
metastases, there must be at least one other site of metastasis in addition to
the liver to be eligible for this study.
- Metastatic lesions must be amenable to any combination of surgical resection,
microwave ablation, and/or stereotactic ablative body radiation therapy (SABR).
SABR is required for at least one lesion. Therefore, the patient must be seen
by a radiation oncologist in consultation to verify eligibility.
- Single sites include:
- Each hemiliver (right and left), each lobe of the lungs, each adrenal
gland, lymph nodes amenable to a single resection or treatment in a single
SABR field, bone metastases amenable to treatment in a single SABR field
- PRE-REGISTRATION (STEP 0): Patients must have measurable disease per Response
Evaluation Criteria in Solid Tumors (RECIST) version (v)1.1
- PRE-REGISTRATION (STEP 0): A maximum of 16 weeks (4 months) of systemic therapy may
be administered prior to pre-registration
- REGISTRATION (STEP 1): Patients must have no overt evidence of disease progression
during systemic therapy prior to registration
- REGISTRATION (STEP 1): Not eligible for hepatic artery infusion pump (HAIP) therapy
or benefit of HAIP therapy is undefined
- REGISTRATION (STEP 1): Patients must have measurable disease per RECIST v1.1
- REGISTRATION (STEP 1): Patients must be receiving (or have received) first-line
systemic therapy for metastatic disease for a minimum of 16 weeks (4 months) and a
maximum of 24 weeks (6 months)
- REGISTRATION (STEP 1): Prior definitive therapy, including adjuvant chemotherapy,
must have been completed at least 12 months prior to diagnosis of metastatic disease
- REGISTRATION (STEP 1): Not pregnant and not nursing, because this study involves an
agent or treatment that has known genotoxic, mutagenic, and teratogenic effects.
* Therefore, for women of childbearing potential only, a negative pregnancy test
done =< 14 days prior to registration is required
- REGISTRATION (STEP 1): Age >= 18 years
- REGISTRATION (STEP 1): Eastern Cooperative Oncology Group (ECOG) performance status:
0-2
- REGISTRATION (STEP 1): Absolute neutrophil count (ANC) >= 1,500/mm^3
- REGISTRATION (STEP 1): Platelet count >= 50,000/mm^3
- REGISTRATION (STEP 1): Creatinine =< 1.5 x upper limit of normal (ULN) OR calculated
(calc.) creatinine clearance >= 30 mL/min
* Calculated using the Cockcroft-Gault equation
- REGISTRATION (STEP 1): Total bilirubin =< 1.5 x ULN
- REGISTRATION (STEP 1): Aspartate aminotransferase (AST)(serum glutamic-oxaloacetic
transaminase [SGOT]) / alanine aminotransferase (ALT)(serum glutamate pyruvate
transaminase [SGPT]) =< 3.0 x ULN
* In the event of metastatic liver disease, =< 5 x ULN
- REGISTRATION (STEP 1): Human immunodeficiency virus (HIV)-infected patients on
effective anti-retroviral therapy with undetectable viral load within 6 months are
eligible for this trial. Note: HIV testing is not required for eligibility
- REGISTRATION (STEP 1): No other planned concurrent investigational agents while on
study
Exclusion Criteria:
- N/A
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Kingman Regional Medical Center
Address:
City:
Kingman
Zip:
86401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
702-384-0013
Email:
research@sncrf.org
Investigator:
Last name:
John A. Ellerton
Email:
Principal Investigator
Facility:
Name:
Mayo Clinic Hospital in Arizona
Address:
City:
Phoenix
Zip:
85054
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
855-776-0015
Investigator:
Last name:
Christina S. Wu
Email:
Principal Investigator
Facility:
Name:
Tower Cancer Research Foundation
Address:
City:
Beverly Hills
Zip:
90211
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
towercancerresearch@toweroncology.com
Investigator:
Last name:
Jun Gong
Email:
Principal Investigator
Facility:
Name:
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Address:
City:
Irvine
Zip:
92612
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-827-8839
Email:
ucstudy@uci.edu
Investigator:
Last name:
Oliver S. Eng
Email:
Principal Investigator
Facility:
Name:
Cedars Sinai Medical Center
Address:
City:
Los Angeles
Zip:
90048
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
310-423-8965
Investigator:
Last name:
Jun Gong
Email:
Principal Investigator
Facility:
Name:
UC Irvine Health/Chao Family Comprehensive Cancer Center
Address:
City:
Orange
Zip:
92868
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-827-8839
Email:
ucstudy@uci.edu
Investigator:
Last name:
Oliver S. Eng
Email:
Principal Investigator
Facility:
Name:
University of California Davis Comprehensive Cancer Center
Address:
City:
Sacramento
Zip:
95817
Country:
United States
Status:
Active, not recruiting
Facility:
Name:
Helen F Graham Cancer Center
Address:
City:
Newark
Zip:
19713
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-623-4450
Email:
lbarone@christianacare.org
Investigator:
Last name:
Gregory A. Masters
Email:
Principal Investigator
Facility:
Name:
Medical Oncology Hematology Consultants PA
Address:
City:
Newark
Zip:
19713
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-623-4450
Email:
lbarone@christianacare.org
Investigator:
Last name:
Gregory A. Masters
Email:
Principal Investigator
Facility:
Name:
Christiana Care Health System-Christiana Hospital
Address:
City:
Newark
Zip:
19718
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-623-4450
Email:
lbarone@christianacare.org
Investigator:
Last name:
Gregory A. Masters
Email:
Principal Investigator
Facility:
Name:
Sibley Memorial Hospital
Address:
City:
Washington
Zip:
20016
Country:
United States
Status:
Suspended
Facility:
Name:
University of Florida Health Science Center - Gainesville
Address:
City:
Gainesville
Zip:
32610
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
352-273-8010
Email:
cancer-center@ufl.edu
Investigator:
Last name:
Kathryn E. Hitchcock
Email:
Principal Investigator
Facility:
Name:
Grady Health System
Address:
City:
Atlanta
Zip:
30303
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
404-489-9164
Investigator:
Last name:
Pretesh R. Patel
Email:
Principal Investigator
Facility:
Name:
Emory Proton Therapy Center
Address:
City:
Atlanta
Zip:
30308
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
404-251-2854
Email:
allyson.anderson@emory.edu
Investigator:
Last name:
Pretesh R. Patel
Email:
Principal Investigator
Facility:
Name:
Emory University Hospital Midtown
Address:
City:
Atlanta
Zip:
30308
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-946-7447
Investigator:
Last name:
Pretesh R. Patel
Email:
Principal Investigator
Facility:
Name:
Emory University Hospital/Winship Cancer Institute
Address:
City:
Atlanta
Zip:
30322
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
404-778-1868
Investigator:
Last name:
Pretesh R. Patel
Email:
Principal Investigator
Facility:
Name:
Emory Saint Joseph's Hospital
Address:
City:
Atlanta
Zip:
30342
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
404-851-7115
Investigator:
Last name:
Pretesh R. Patel
Email:
Principal Investigator
Facility:
Name:
Saint Luke's Cancer Institute - Boise
Address:
City:
Boise
Zip:
83712
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
208-381-2774
Email:
eslinget@slhs.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Saint Luke's Cancer Institute - Fruitland
Address:
City:
Fruitland
Zip:
83619
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
208-381-2774
Email:
eslinget@slhs.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Saint Luke's Cancer Institute - Meridian
Address:
City:
Meridian
Zip:
83642
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
208-381-2774
Email:
eslinget@slhs.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Saint Luke's Cancer Institute - Nampa
Address:
City:
Nampa
Zip:
83686
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
208-381-2774
Email:
eslinget@slhs.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Saint Luke's Cancer Institute - Twin Falls
Address:
City:
Twin Falls
Zip:
83301
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
208-381-2774
Email:
eslinget@slhs.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
University of Illinois
Address:
City:
Chicago
Zip:
60612
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
312-355-3046
Investigator:
Last name:
Aslam Ejaz
Email:
Principal Investigator
Facility:
Name:
Mission Cancer and Blood - Ankeny
Address:
City:
Ankeny
Zip:
50023
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-282-2921
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
Mercy Cancer Center-West Lakes
Address:
City:
Clive
Zip:
50325
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-358-6613
Email:
cancerresearch@mercydesmoines.org
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
Mission Cancer and Blood - West Des Moines
Address:
City:
Clive
Zip:
50325
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-241-3305
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
Greater Regional Medical Center
Address:
City:
Creston
Zip:
50801
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-358-6613
Email:
cancerresearch@mercydesmoines.org
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
Iowa Methodist Medical Center
Address:
City:
Des Moines
Zip:
50309
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-241-6727
Investigator:
Last name:
Seema Harichand-Herdt
Email:
Principal Investigator
Facility:
Name:
Mission Cancer and Blood - Des Moines
Address:
City:
Des Moines
Zip:
50309
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-241-3305
Investigator:
Last name:
Seema Harichand-Herdt
Email:
Principal Investigator
Facility:
Name:
Mercy Medical Center - Des Moines
Address:
City:
Des Moines
Zip:
50314
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-358-6613
Email:
cancerresearch@mercydesmoines.org
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
Mission Cancer and Blood - Laurel
Address:
City:
Des Moines
Zip:
50314
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-241-3305
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
Mercy Medical Center-West Lakes
Address:
City:
West Des Moines
Zip:
50266
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-358-6613
Email:
cancerresearch@mercydesmoines.org
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
University of Kentucky/Markey Cancer Center
Address:
City:
Lexington
Zip:
40536
Country:
United States
Status:
Active, not recruiting
Facility:
Name:
Johns Hopkins University/Sidney Kimmel Cancer Center
Address:
City:
Baltimore
Zip:
21287
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
410-955-8804
Email:
jhcccro@jhmi.edu
Investigator:
Last name:
Eric Christenson
Email:
Principal Investigator
Facility:
Name:
Trinity Health Saint Joseph Mercy Hospital Ann Arbor
Address:
City:
Ann Arbor
Zip:
48106
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Brighton
Address:
City:
Brighton
Zip:
48114
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Trinity Health Medical Center - Brighton
Address:
City:
Brighton
Zip:
48114
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Canton
Address:
City:
Canton
Zip:
48188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Trinity Health Medical Center - Canton
Address:
City:
Canton
Zip:
48188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Chelsea Hospital
Address:
City:
Chelsea
Zip:
48118
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
Address:
City:
Chelsea
Zip:
48118
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Corewell Health Dearborn Hospital
Address:
City:
Dearborn
Zip:
48124
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-551-7695
Investigator:
Last name:
Kuei C. Lee
Email:
Principal Investigator
Facility:
Name:
Henry Ford Hospital
Address:
City:
Detroit
Zip:
48202
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
313-916-3721
Email:
CTOResearch@hfhs.org
Investigator:
Last name:
Parag J. Parikh
Email:
Principal Investigator
Facility:
Name:
Corewell Health Farmington Hills Hospital
Address:
City:
Farmington Hills
Zip:
48336
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-551-7695
Investigator:
Last name:
Kuei C. Lee
Email:
Principal Investigator
Facility:
Name:
Genesys Hurley Cancer Institute
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Hurley Medical Center
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
University of Michigan Health - Sparrow Lansing
Address:
City:
Lansing
Zip:
48912
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
517-364-3712
Email:
harsha.trivedi@umhsparrow.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Trinity Health Saint Mary Mercy Livonia Hospital
Address:
City:
Livonia
Zip:
48154
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Henry Ford Health Providence Novi Hospital
Address:
City:
Novi
Zip:
48374
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-849-5332
Email:
kfife3@hfhs.org
Investigator:
Last name:
Adam M. Forman
Email:
Principal Investigator
Facility:
Name:
Corewell Health William Beaumont University Hospital
Address:
City:
Royal Oak
Zip:
48073
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-551-7695
Investigator:
Last name:
Kuei C. Lee
Email:
Principal Investigator
Facility:
Name:
Henry Ford Health Providence Southfield Hospital
Address:
City:
Southfield
Zip:
48075
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-849-5332
Email:
kfife3@hfhs.org
Investigator:
Last name:
Adam M. Forman
Email:
Principal Investigator
Facility:
Name:
Corewell Health Beaumont Troy Hospital
Address:
City:
Troy
Zip:
48085
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-551-7695
Investigator:
Last name:
Kuei C. Lee
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
Address:
City:
Ypsilanti
Zip:
48197
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Sanford Joe Lueken Cancer Center
Address:
City:
Bemidji
Zip:
56601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-333-5000
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Baptist Memorial Hospital and Cancer Center-Golden Triangle
Address:
City:
Columbus
Zip:
39705
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
901-226-1366
Email:
BCCclintrials@bmhcc.org
Investigator:
Last name:
Aleksandar Jankov
Email:
Principal Investigator
Facility:
Name:
Baptist Cancer Center-Grenada
Address:
City:
Grenada
Zip:
38901
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
901-226-1366
Email:
BCCclintrials@bmhcc.org
Investigator:
Last name:
Aleksandar Jankov
Email:
Principal Investigator
Facility:
Name:
Baptist Memorial Hospital and Cancer Center-Union County
Address:
City:
New Albany
Zip:
38652
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
901-226-1366
Email:
BCCclintrials@bmhcc.org
Investigator:
Last name:
Aleksandar Jankov
Email:
Principal Investigator
Facility:
Name:
Baptist Memorial Hospital and Cancer Center-Oxford
Address:
City:
Oxford
Zip:
38655
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
901-226-1366
Email:
BCCclintrials@bmhcc.org
Investigator:
Last name:
Aleksandar Jankov
Email:
Principal Investigator
Facility:
Name:
Baptist Memorial Hospital and Cancer Center-Desoto
Address:
City:
Southhaven
Zip:
38671
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
901-226-1366
Email:
BCCclintrials@bmhcc.org
Investigator:
Last name:
Aleksandar Jankov
Email:
Principal Investigator
Facility:
Name:
Mercy Hospital Saint Louis
Address:
City:
Saint Louis
Zip:
63141
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-251-7066
Investigator:
Last name:
Jay W. Carlson
Email:
Principal Investigator
Facility:
Name:
Billings Clinic Cancer Center
Address:
City:
Billings
Zip:
59101
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-996-2663
Email:
research@billingsclinic.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Benefis Sletten Cancer Institute
Address:
City:
Great Falls
Zip:
59405
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Nebraska Medicine-Bellevue
Address:
City:
Bellevue
Zip:
68123
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
402-559-6941
Email:
unmcrsa@unmc.edu
Investigator:
Last name:
Laura L. Tenner
Email:
Principal Investigator
Facility:
Name:
Nebraska Medicine-Village Pointe
Address:
City:
Omaha
Zip:
68118
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
402-559-5600
Investigator:
Last name:
Laura L. Tenner
Email:
Principal Investigator
Facility:
Name:
University of Nebraska Medical Center
Address:
City:
Omaha
Zip:
68198
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
402-559-6941
Email:
unmcrsa@unmc.edu
Investigator:
Last name:
Laura L. Tenner
Email:
Principal Investigator
Facility:
Name:
Renown Regional Medical Center
Address:
City:
Reno
Zip:
89502
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
702-384-0013
Email:
research@sncrf.org
Investigator:
Last name:
John A. Ellerton
Email:
Principal Investigator
Facility:
Name:
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
Address:
City:
Lebanon
Zip:
03756
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-639-6918
Email:
cancer.research.nurse@dartmouth.edu
Investigator:
Last name:
Kathryn C. Hourdequin
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Basking Ridge
Address:
City:
Basking Ridge
Zip:
07920
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
Vonetta M. Williams
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Monmouth
Address:
City:
Middletown
Zip:
07748
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
Vonetta M. Williams
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Bergen
Address:
City:
Montvale
Zip:
07645
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
Vonetta M. Williams
Email:
Principal Investigator
Facility:
Name:
University of New Mexico Cancer Center
Address:
City:
Albuquerque
Zip:
87106
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
505-925-0348
Email:
HSC-ClinicalTrialInfo@salud.unm.edu
Investigator:
Last name:
Benny J. Liem
Email:
Principal Investigator
Facility:
Name:
New York-Presbyterian/Brooklyn Methodist Hospital
Address:
City:
Brooklyn
Zip:
11215
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
718-780-3677
Email:
Adg9003@nyp.org
Investigator:
Last name:
Uqba Khan
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Commack
Address:
City:
Commack
Zip:
11725
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
Vonetta M. Williams
Email:
Principal Investigator
Facility:
Name:
The New York Hospital Medical Center of Queens
Address:
City:
Flushing
Zip:
11355
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-823-5923
Email:
ctsucontact@westat.com
Investigator:
Last name:
Jini Hyun
Email:
Principal Investigator
Facility:
Name:
Northwell Health Physicians Partners Radiation Medicine at Queens
Address:
City:
Forest Hills
Zip:
11375
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
718-520-6620
Investigator:
Last name:
Sepideh Gholami
Email:
Principal Investigator
Facility:
Name:
Northwell Health Cancer Institute at Huntington
Address:
City:
Greenlawn
Zip:
11740
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
516-734-8896
Investigator:
Last name:
Sepideh Gholami
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Westchester
Address:
City:
Harrison
Zip:
10604
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
Vonetta M. Williams
Email:
Principal Investigator
Facility:
Name:
Northwell Health/Center for Advanced Medicine
Address:
City:
Lake Success
Zip:
11042
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
516-734-8896
Investigator:
Last name:
Sepideh Gholami
Email:
Principal Investigator
Facility:
Name:
Northern Westchester Hospital
Address:
City:
Mount Kisco
Zip:
10549
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
914-666-1366
Email:
AMellor@northwell.edu
Investigator:
Last name:
Sepideh Gholami
Email:
Principal Investigator
Facility:
Name:
Mount Sinai West
Address:
City:
New York
Zip:
10019
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-824-7309
Email:
CCTO@mssm.edu
Investigator:
Last name:
Karyn A. Goodman
Email:
Principal Investigator
Facility:
Name:
Lenox Hill Hospital
Address:
City:
New York
Zip:
10021
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
516-734-8896
Investigator:
Last name:
Sepideh Gholami
Email:
Principal Investigator
Facility:
Name:
Mount Sinai Hospital
Address:
City:
New York
Zip:
10029
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-824-7309
Email:
CCTO@mssm.edu
Investigator:
Last name:
Karyn A. Goodman
Email:
Principal Investigator
Facility:
Name:
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
Address:
City:
New York
Zip:
10032
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-342-5162
Email:
cancerclinicaltrials@cumc.columbia.edu
Investigator:
Last name:
David P. Horowitz
Email:
Principal Investigator
Facility:
Name:
Manhattan Eye Ear and Throat Hospital
Address:
City:
New York
Zip:
10065
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-434-4460
Investigator:
Last name:
Sepideh Gholami
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Cancer Center
Address:
City:
New York
Zip:
10065
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
Vonetta M. Williams
Email:
Principal Investigator
Facility:
Name:
NYP/Weill Cornell Medical Center
Address:
City:
New York
Zip:
10065
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-746-1848
Investigator:
Last name:
Allyson J. Ocean
Email:
Principal Investigator
Facility:
Name:
Queens Cancer Center
Address:
City:
Rego Park
Zip:
11374
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
718-312-3446
Investigator:
Last name:
Sepideh Gholami
Email:
Principal Investigator
Facility:
Name:
University of Rochester
Address:
City:
Rochester
Zip:
14642
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
585-275-5830
Investigator:
Last name:
Yuhchyau Chen
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Nassau
Address:
City:
Uniondale
Zip:
11553
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
Vonetta M. Williams
Email:
Principal Investigator
Facility:
Name:
Westchester Medical Center
Address:
City:
Valhalla
Zip:
10595
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-823-5923
Email:
ctsucontact@westat.com
Investigator:
Last name:
Aviva Berkowitz
Email:
Principal Investigator
Facility:
Name:
Wilmot Cancer Institute at Webster
Address:
City:
Webster
Zip:
14580
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
WCICTOresearch@urmc.rochester.edu
Investigator:
Last name:
Yuhchyau Chen
Email:
Principal Investigator
Facility:
Name:
Sanford Bismarck Medical Center
Address:
City:
Bismarck
Zip:
58501
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
701-323-5760
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Sanford Broadway Medical Center
Address:
City:
Fargo
Zip:
58122
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
701-323-5760
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Sanford Roger Maris Cancer Center
Address:
City:
Fargo
Zip:
58122
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
701-234-6161
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Dayton Physicians LLC-Miami Valley South
Address:
City:
Centerville
Zip:
45459
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-528-2900
Email:
clinical.trials@daytonncorp.org
Investigator:
Last name:
Howard M. Gross
Email:
Principal Investigator
Facility:
Name:
Miami Valley Hospital South
Address:
City:
Centerville
Zip:
45459
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-528-2900
Email:
clinical.trials@daytonncorp.org
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
MetroHealth Medical Center
Address:
City:
Cleveland
Zip:
44109
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
216-778-7559
Email:
ababal@metrohealth.org
Investigator:
Last name:
Suzanne M. Russo
Email:
Principal Investigator
Facility:
Name:
Ohio State University Comprehensive Cancer Center
Address:
City:
Columbus
Zip:
43210
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-293-5066
Email:
Jamesline@osumc.edu
Investigator:
Last name:
Eric D. Miller
Email:
Principal Investigator
Facility:
Name:
Miami Valley Hospital
Address:
City:
Dayton
Zip:
45409
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-528-2900
Email:
clinical.trials@daytonncorp.org
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
Premier Blood and Cancer Center
Address:
City:
Dayton
Zip:
45409
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-276-8320
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
Dayton Physician LLC - Englewood
Address:
City:
Dayton
Zip:
45415
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-528-2900
Email:
clinical.trials@daytonncorp.org
Investigator:
Last name:
Howard M. Gross
Email:
Principal Investigator
Facility:
Name:
Miami Valley Hospital North
Address:
City:
Dayton
Zip:
45415
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-528-2900
Email:
clinical.trials@daytonncorp.org
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
Atrium Medical Center-Middletown Regional Hospital
Address:
City:
Franklin
Zip:
45005-1066
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-528-2900
Email:
clinical.trials@daytonncorp.org
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
Dayton Physicians LLC-Atrium
Address:
City:
Franklin
Zip:
45005
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-528-2900
Email:
clinical.trials@daytonncorp.org
Investigator:
Last name:
Howard M. Gross
Email:
Principal Investigator
Facility:
Name:
Miami Valley Cancer Care and Infusion
Address:
City:
Greenville
Zip:
45331
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-569-7515
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
Upper Valley Medical Center
Address:
City:
Troy
Zip:
45373
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-528-2900
Email:
clinical.trials@daytonncorp.org
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
University of Oklahoma Health Sciences Center
Address:
City:
Oklahoma City
Zip:
73104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
405-271-8777
Email:
ou-clinical-trials@ouhsc.edu
Investigator:
Last name:
Sagila George
Email:
Principal Investigator
Facility:
Name:
Christiana Care Health System-Concord Health Center
Address:
City:
Chadds Ford
Zip:
19317
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-623-4450
Email:
lbarone@christianacare.org
Investigator:
Last name:
Gregory A. Masters
Email:
Principal Investigator
Facility:
Name:
Geisinger Medical Center
Address:
City:
Danville
Zip:
17822
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
570-271-5251
Email:
HemonCCTrials@geisinger.edu
Investigator:
Last name:
Alfred D. Christie
Email:
Principal Investigator
Facility:
Name:
Geisinger Medical Oncology-Lewisburg
Address:
City:
Lewisburg
Zip:
17837
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
570-374-8555
Email:
HemonCCTrials@geisinger.edu
Investigator:
Last name:
Alfred D. Christie
Email:
Principal Investigator
Facility:
Name:
Allegheny General Hospital
Address:
City:
Pittsburgh
Zip:
15212
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-284-2000
Investigator:
Last name:
Patrick L. Wagner
Email:
Principal Investigator
Facility:
Name:
West Penn Hospital
Address:
City:
Pittsburgh
Zip:
15224
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
412-578-5000
Investigator:
Last name:
Patrick L. Wagner
Email:
Principal Investigator
Facility:
Name:
Geisinger Wyoming Valley/Henry Cancer Center
Address:
City:
Wilkes-Barre
Zip:
18711
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
570-271-5251
Email:
HemonCCTrials@geisinger.edu
Investigator:
Last name:
Alfred D. Christie
Email:
Principal Investigator
Facility:
Name:
Sanford Cancer Center Oncology Clinic
Address:
City:
Sioux Falls
Zip:
57104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
605-312-3320
Email:
OncologyClinicTrialsSF@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Sanford USD Medical Center - Sioux Falls
Address:
City:
Sioux Falls
Zip:
57117-5134
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
605-312-3320
Email:
OncologyClinicalTrialsSF@SanfordHealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Baptist Memorial Hospital and Cancer Center-Memphis
Address:
City:
Memphis
Zip:
38120
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
901-226-1366
Email:
BCCclintrials@bmhcc.org
Investigator:
Last name:
Aleksandar Jankov
Email:
Principal Investigator
Facility:
Name:
Vanderbilt University/Ingram Cancer Center
Address:
City:
Nashville
Zip:
37232
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-811-8480
Investigator:
Last name:
Chandrasekhar Padmanabhan
Email:
Principal Investigator
Facility:
Name:
University of Texas Health Science Center at San Antonio
Address:
City:
San Antonio
Zip:
78229
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
210-450-3800
Email:
phoresearchoffice@uthscsa.edu
Investigator:
Last name:
Neil Newman
Email:
Principal Investigator
Facility:
Name:
Huntsman Cancer Institute/University of Utah
Address:
City:
Salt Lake City
Zip:
84112
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-424-2100
Email:
cancerinfo@hci.utah.edu
Investigator:
Last name:
Shane Lloyd
Email:
Principal Investigator
Facility:
Name:
Valley Medical Center
Address:
City:
Renton
Zip:
98055
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
425-228-3440
Email:
research@valleymed.org
Investigator:
Last name:
John A. Ellerton
Email:
Principal Investigator
Facility:
Name:
Langlade Hospital and Cancer Center
Address:
City:
Antigo
Zip:
54409
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
715-623-9869
Email:
Juli.Alford@aspirus.org
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Facility:
Name:
Medical College of Wisconsin
Address:
City:
Milwaukee
Zip:
53226
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-805-3666
Investigator:
Last name:
William A. Hall
Email:
Principal Investigator
Facility:
Name:
Ascension Saint Mary's Hospital
Address:
City:
Rhinelander
Zip:
54501
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
715-847-2353
Email:
Beth.Knetter@aspirus.org
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Facility:
Name:
Ascension Saint Michael's Hospital
Address:
City:
Stevens Point
Zip:
54481
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
715-847-2353
Email:
Beth.Knetter@aspirus.org
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Facility:
Name:
Aspirus Cancer Care - Wisconsin Rapids
Address:
City:
Wisconsin Rapids
Zip:
54494
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
715-422-7718
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Start date:
January 10, 2023
Completion date:
August 12, 2032
Lead sponsor:
Agency:
Alliance for Clinical Trials in Oncology
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
Alliance for Clinical Trials in Oncology
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05673148